Maravai LifeSciences Holdings, Inc. Research and Development Expense
Maravai LifeSciences Holdings, Inc. (MRVI) reported Research and Development Expense of $3.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. research and development expense for the quarter ending 2026-06-30 was $3.70M, a 24.17% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. research and development expense for the quarter ending 2026-03-31 was $3.89M, a 20.44% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. research and development expense for the quarter ending 2025-12-31 was $3.79M, a 16.95% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. research and development expense for the quarter ending 2025-09-30 was $3.84M, a 18.28% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. research and development expense for fiscal 2025 was $17.40M, a 9.46% decline from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. research and development expense for fiscal 2024 was $19.22M, a 11.23% increase from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. research and development expense for fiscal 2023 was $17.28M, a 5.93% decline from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. research and development expense for fiscal 2022 was $18.37M, a 20.70% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.70M 10-Q · filed 2026-08-07 | $7.59M 10-Q · filed 2026-08-07 | $11.38M derived: sum of 3 quarters · filed 2026-08-07 | $15.22M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | $3.89M 10-Q · filed 2026-05-08 | $7.68M derived: sum of 2 quarters · filed 2026-05-08 | $11.52M derived: sum of 3 quarters · filed 2026-05-08 | $16.40M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | $3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.63M derived: sum of 2 quarters · filed 2026-02-26 | $12.51M derived: sum of 3 quarters · filed 2026-08-07 | $17.40M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $3.84M 10-Q · filed 2025-11-07 | $8.73M derived: sum of 2 quarters · filed 2026-08-07 | $13.61M 10-Q · filed 2025-11-07 | $18.18M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | $4.88M 10-Q · filed 2026-08-07 | $9.77M 10-Q · filed 2026-08-07 | $14.33M derived: sum of 3 quarters · filed 2026-08-07 | $19.04M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $4.89M 10-Q · filed 2026-05-08 | $9.45M derived: sum of 2 quarters · filed 2026-05-08 | $14.15M derived: sum of 3 quarters · filed 2026-05-08 | $19.08M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.27M derived: sum of 2 quarters · filed 2026-02-26 | $14.19M derived: sum of 3 quarters · filed 2026-02-26 | $19.22M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $4.70M 10-Q · filed 2025-11-07 | $4.34M 10-Q · filed 2024-11-12 | $9.63M derived: sum of 2 quarters · filed 2025-11-07 | $14.66M 10-Q · filed 2025-11-07 | $19.25M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $4.92M 10-Q · filed 2025-08-11 | $5.28M 10-Q · filed 2024-08-08 | $9.96M 10-Q · filed 2025-08-11 | $10.32M 10-Q · filed 2024-08-08 | $14.55M derived: sum of 3 quarters · filed 2026-02-26 | $18.90M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $5.03M 10-Q · filed 2025-05-12 | $9.63M derived: sum of 2 quarters · filed 2026-02-26 | $13.97M derived: sum of 3 quarters · filed 2026-02-26 | $18.17M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.94M derived: sum of 2 quarters · filed 2026-02-26 | $13.13M derived: sum of 3 quarters · filed 2026-02-26 | $17.28M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $4.35M 10-Q · filed 2024-11-12 | $8.54M derived: sum of 2 quarters · filed 2024-11-12 | $12.69M 10-Q · filed 2024-11-12 | $17.70M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-06-30 | $4.19M 10-Q · filed 2024-08-08 | $8.34M 10-Q · filed 2024-08-08 | $13.35M derived: sum of 3 quarters · filed 2025-03-18 | $18.74M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-03-31 | $4.14M 10-Q · filed 2024-05-09 | $9.16M derived: sum of 2 quarters · filed 2025-03-18 | $14.54M derived: sum of 3 quarters · filed 2025-03-18 | $18.82M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2022-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $10.40M derived: sum of 2 quarters · filed 2025-03-18 | $14.67M derived: sum of 3 quarters · filed 2025-03-18 | $18.37M 10-K · filed 2025-03-18 | |||
| 2022-09-30 | $5.39M 10-Q · filed 2023-11-08 | $9.66M derived: sum of 2 quarters · filed 2023-11-08 | $13.36M 10-Q · filed 2023-11-08 | $22.54M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $4.27M 10-Q · filed 2023-08-08 | $7.97M 10-Q · filed 2023-08-08 | $17.15M derived: sum of 3 quarters · filed 2024-02-29 | $19.10M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $3.69M 10-Q · filed 2023-05-09 | $12.88M derived: sum of 2 quarters · filed 2024-02-29 | $14.82M derived: sum of 3 quarters · filed 2024-02-29 | $16.75M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $9.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $11.13M derived: sum of 2 quarters · filed 2024-02-29 | $13.06M derived: sum of 3 quarters · filed 2024-02-29 | $15.22M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $1.95M 10-Q · filed 2022-11-04 | $1.95M 10-Q · filed 2021-11-15 | $3.88M derived: sum of 2 quarters · filed 2022-11-04 | $6.04M 10-Q · filed 2022-11-04 | $6.05M 10-Q · filed 2021-11-15 | $8.13M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $1.93M 10-Q · filed 2022-08-05 | $1.93M 10-Q · filed 2021-08-11 | $4.09M 10-Q · filed 2022-08-05 | $4.10M 10-Q · filed 2021-08-11 | $6.18M derived: sum of 3 quarters · filed 2023-02-28 | $8.05M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $2.16M 10-Q · filed 2022-05-06 | $2.16M 10-Q · filed 2021-05-12 | $4.25M derived: sum of 2 quarters · filed 2023-02-28 | $6.12M derived: sum of 3 quarters · filed 2023-02-28 | $7.72M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $3.96M derived: sum of 2 quarters · filed 2023-02-28 | $5.56M derived: sum of 3 quarters · filed 2023-02-28 | $9.30M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $1.87M 10-Q · filed 2021-11-15 | $3.47M derived: sum of 2 quarters · filed 2021-11-15 | $7.21M 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $1.60M 10-Q · filed 2021-08-11 | $5.34M 10-Q · filed 2021-08-11 | |||||
| 2020-03-31 | $3.74M 10-Q · filed 2021-05-12 | ||||||
| 2019-12-31 | $3.63M 10-K · filed 2022-03-01 |